LYKA LABS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Lyka Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
5.23₹ 3.79
As on Jan 22, 2026, 4:01 PM IST
Lyka Labs Price Performance
Today's LowToday's High
₹74.02₹76.22
₹76.22
52 Weeks' Low52 Weeks' High
₹71.99₹163.40
₹76.22
Open Price
₹75.50
Prev. Close
₹72.43
Volume
3,428
Over the last 5 years, the share price of Lyka Labs has gained 20.87% CAGR. Over the past year, the corresponding return has been -50.23%.
Lyka Labs’s current P/E of 132.56x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Lyka Labs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lyka Labs | -0.31 | 0.03 | -21.32 | -32.90 | -50.23 | -17.55 | 20.87 |
| Sun Pharmaceutical Industries | -3.89 | -7.73 | -3.23 | -2.60 | -9.10 | 15.91 | 23.23 |
| Divi's Laboratories | -4.34 | -6.62 | -7.32 | -8.02 | 4.41 | 21.56 | 11.40 |
| Torrent Pharmaceuticals | 0.63 | 5.65 | 11.41 | 15.03 | 27.26 | 36.16 | 24.53 |
| Cipla | -4.18 | -9.12 | -16.45 | -6.17 | -4.50 | 8.96 | 11.21 |
| Dr. Reddy's Laboratories | 2.59 | -5.20 | -4.90 | -1.87 | -6.11 | 11.94 | 3.87 |
| Lupin | -1.35 | 1.84 | 11.61 | 13.79 | 1.25 | 41.42 | 14.94 |
| Zydus Lifesciences | -0.02 | -3.74 | -12.30 | -7.58 | -9.71 | 25.81 | 13.94 |
| Mankind Pharma | -4.17 | -1.70 | -12.21 | -19.48 | -14.50 | 14.72 | 8.59 |
| Alkem Laboratories | -1.13 | 2.56 | 4.21 | 15.90 | 11.87 | 23.74 | 13.69 |
| Aurobindo Pharma | -3.10 | -6.58 | 4.07 | 3.86 | -3.99 | 36.90 | 4.37 |
| Biocon | -1.69 | -6.62 | 2.84 | -3.72 | -3.92 | 14.48 | -1.10 |
| Abbott India | -0.72 | -1.09 | -7.97 | -18.99 | -0.17 | 8.25 | 13.96 |
| Glenmark Pharmaceuticals | -0.78 | -2.09 | 7.90 | -7.51 | 32.95 | 68.30 | 32.15 |
| Laurus Labs | -7.89 | -5.50 | 7.28 | 22.00 | 75.86 | 42.37 | 22.08 |
| GlaxoSmithKline Pharmaceuticals | -0.08 | -5.24 | -13.36 | -22.83 | 13.22 | 23.23 | 9.51 |
| Ipca Laboratories | -2.00 | 4.19 | 16.64 | 1.82 | -4.67 | 19.42 | 7.75 |
| Anthem Biosciences | -2.83 | -11.12 | -15.77 | -17.47 | -17.16 | -6.08 | -3.70 |
| Ajanta Pharma | 0.21 | 0.38 | 12.23 | -1.03 | -5.09 | 31.33 | 18.77 |
| J B Chemicals & Pharmaceuticals | 0.28 | 5.08 | 11.28 | 12.46 | 5.40 | 24.44 | 30.77 |
Over the last one year, Lyka Labs has declined 50.23% compared to peers like Sun Pharmaceutical Industries (-9.10%), Divi's Laboratories (4.41%), Torrent Pharmaceuticals (27.26%). From a 5 year perspective, Lyka Labs has outperformed peers relative to Sun Pharmaceutical Industries (23.23%) and Divi's Laboratories (11.40%).
Lyka Labs Financials
Lyka Labs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 76.77 | 75.21 |
| 10 | 78.22 | 76.54 |
| 20 | 77.78 | 77.46 |
| 50 | 80.07 | 80.88 |
| 100 | 88.59 | 87.48 |
| 200 | 99.92 | 97.81 |
Lyka Labs Share Holding Pattern
In the latest quarter, Lyka Labs remained same as its previous close in promoter holding, while DII stake unchanged at 0.66%, FII holding unchanged at 0.17%, and public shareholding unchanged at 40.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Lyka Labs Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 14, 2026, 6:31 PM IST | Lyka Labs - Board Meeting Intimation for Board Meeting To Be Held On 29Th January, 2026 |
| Jan 07, 2026, 6:50 PM IST | Lyka Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 22, 2025, 9:40 PM IST | Lyka Labs - Update On The Scheme Of Amalgamation |
| Dec 05, 2025, 9:38 PM IST | Lyka Labs - Update On The Scheme Of Amalgamation |
| Nov 12, 2025, 8:08 PM IST | Lyka Labs - Financial Results For The Quarter 30Th September 2025 |
About Lyka Labs
Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 134.70 Cr. and Equity Capital is Rs. 35.69 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address4801/B & 4802/A, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Babulal JainChairman
- Mr. Kunal GandhiManaging Director & CEO
- Mr. Yogesh B ShahWholeTime Director & CFO
- Mr. Shashil MendosaNon Executive Director
- Mr. Prashant GodhaNon Executive Director
- Mrs. Dhara ShahIndependent Director
- Mr. Neeraj GolasIndependent Director
- Ms. Archana S YadavIndependent Director
FAQs on Lyka Labs Share Price
What is the share price of Lyka Labs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lyka Labs is ₹76.22 as on Jan 22, 2026.
What kind of stock is Lyka Labs?
The Lyka Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Lyka Labs?
The market cap of Lyka Labs is ₹272.03 Cr as on Jan 22, 2026.
What are today's High and Low prices of Lyka Labs?
Today’s highest and lowest price of Lyka Labs are ₹76.22 and ₹74.02.
What are the 52 Week High and 52 Week Low of Lyka Labs?
The 52-week high/low is the highest and lowest price at which Lyka Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Lyka Labs is ₹163.40 and 52-week low of Lyka Labs is ₹71.99 as on Jan 22, 2026.
How has the Lyka Labs performed historically in terms of returns?
The Lyka Labs has shown returns of 5.23% over the past day, 0.03% for the past month, -21.32% over 3 months, -50.23% over 1 year, -17.55% across 3 years, and 20.87% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Lyka Labs?
P/E ratio of and PB ratio of Lyka Labs are 132.56 and 2.69 on Jan 22, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse